JMI LABS IS NOW PART OF LEARN MORE

Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. by Chin JN, Jones RN, Sader HS, Savage PB and Rybak MJ published in J. Antimicrob. Chemother. 2008; 61 (2): 365-370

View publication